Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Observational, Longitudinal Study in Pediatric Patients With Moderate to Severe Atopic Dermatitis Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable

NCT03687359 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT03687359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03687359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Observational, Longitudinal Study in Pediatric Patients With Moderate to Severe Atopic Dermatitis Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable
Lead sponsor
Sanofi
Phase
Observational
Overall status
Active, not recruiting
Start date
August 15, 2019
Completion date
July 23, 2035
Enrollment
1,860 (actual)
Sites
182

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis atopic